Navigation Links
Relieving chronic pain
Date:3/25/2013

Each year, more than 35,000 patients in the United States are implanted with spinal cord stimulators to treat chronic pain. Unfortunately, up to half of such patients receive only very limited pain relief. To help more patients, scientists are developing a new device to deliver therapeutic stimulation in a more targeted way, reaching nerve fibers deep within the spinal cord.

Standard devices, first introduced in 1967, work by delivering a low electrical current to the spinal cord that interferes with the body's pain signals. Such devices, however, are only able to deliver therapeutic current to a thin layer of nerve fibers along the outside of the spinal cord. That's because the electrodes delivering the current are placed within the cerebrospinal fluid, which is itself conductive and so dissipates some of the current.

The new device, called the Human Spinal Cord Modulation System (HSCMS), is designed to be in direct contact with the spinal cord, held in place by a small loop of wire. Because the spinal cord moves during normal patient activity, that loop has to exert enough pressure for the HSCMS to stay in contact with the spinal cord but not so much that the pressure restricts blood flow or causes direct injury.

To test the pressure exerted by the HSCMS's design, researchers attached the device to a silicone model of the spinal cord previously developed to have the same biomechanical characteristics as living tissue. They then slowly compressed the loop, measuring the pressure exerted on the silicone model. The results, which were accepted for publication in the American Institute of Physics (AIP) Journal of Applied Physics, show the device's loop design exerts pressure at a similar level as is normally found on the spinal cords of healthy people, and so passes an important safety test for further development of the device.


'/>"/>
Contact: Catherine Meyers
cmeyers@aip.org
301-209-3088
American Institute of Physics
Source:Eurekalert

Page: 1

Related biology news :

1. Relieving plant stress could eventually help humans relax
2. Are survivors of childhood leukemia and lymphoma at greater risk of chronic fatigue as adults?
3. NIH awards nearly $2 million to 3 NYC institutions for chronic fatigue syndrome research
4. Preventing chronic pain with stress management
5. Virology researcher awarded nearly $2 million to study chronic hepatitis E
6. Loneliness, like chronic stress, taxes the immune system
7. Chronic disease research awarded funding
8. Social synchronicity
9. Chronic kidney disease increases risk of death at all ages
10. Viruses not to blame for chronic fatigue syndrome after all
11. B cell survival holds key to chronic graft vs. host disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... February 28, 2017 , ... Patient travel ... and expertise. Colpitts Clinical Trial Travel and Expense , a division of ... unique need within the biotechnology and pharmaceutical industries in the United States, Europe, ...
(Date:2/28/2017)... , ... February 28, 2017 , ... Over 8,000 recognized ... In a new educational webinar on March 7, DrugDev will gather international ... in this especially difficult area. , Webinar: Overcoming the Challenges of Rare Disease ...
(Date:2/28/2017)... Diego, California (PRWEB) , ... February 28, 2017 ... ... and supports high-growth, high-impact life science and biotechnology companies today announced it ... entrepreneurial communities, will be based out of Durham, NC and will begin work ...
(Date:2/28/2017)... RepliCel Life Sciences Inc. (OTCQB:REPCF) (TSXV:RP) (FRA:P6P2) ("RepliCel" or ... unique biologic products for pattern baldness and thinning hair, ... announced it has recently signed agreements with two European ... RepliCel to get the Company,s commercial-grade RCI-02 dermal injector ... ...
Breaking Biology Technology: